Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
92
days
Passive amyloid-β immunotherapy in Alzheimer’s disease: a multicellular clearance system beyond plaque removal
Authors
Xiaoni Zhan; Chenchen Liu; Changjiang Yu; Nils Lindblom; Tomas Deierborg; Asgeir Kobro-Flatmoen; Gunnar K. Gouras; Gehua WenShow moreShow less
Affiliations
1. School of Forensic Medicine, China Medical University, Shenyang, China; 2. Neural Plasticity and Repair Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 3. Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 4. Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China; 5. Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden; 6. Experimental Neuroinflammation Lab, Department of Experimental Medical Science, Lund University, Lund, Sweden; 7. Kavli Institute for Systems Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway; 8. Norwegian Health Association Centre for Dementia Research, Norwegian University of Science and Technology (NTNU), Postbox, Trondheim, NorwayShow moreShow less
39
days
Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer’s disease
Authors
Jeff Y. L. Lam; Guojun BuShow moreShow less
Affiliations
1. Division of Life Science and State Key Laboratory of Nervous System Disorders, The Hong Kong University of Science and Technology, Hong Kong, ChinaShow moreShow less
56
days
A reappraisal of APOE genetic effects on Alzheimer’s disease risk in the Japanese population: a meta-analysis
Authors
Akinori Miyashita; Norikazu Hara; Ai Obinata; Tamao Tsukie; Mai Hasegawa; Takanobu Ishiguro; Kensaku Kasuga; Masataka Kikuchi; Tadafumi Hashimoto; Takahisa Kanekiyo; Takeshi IkeuchiShow moreShow less
Affiliations
1. Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan; 2. Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan; 3. Department of Diagnostic Innovation Science, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan; 4. Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan; 5. Department of Neuroscience, Mayo Clinic, Jacksonville, USAShow moreShow less
74
days
RAN translation as a dominant pathogenic axis in C9ORF72-associated ALS and FTD models
Authors
Pegah Masrori; Defne Audrey AmadoShow moreShow less
Affiliations
1. Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2. Institute of Neuroscience, UCLouvain, Brussels, Belgium; 3. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 4. Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, USAShow moreShow less
220
days
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer’s disease
Authors
Arthur C. Macedo; Lydia Trudel; Seyyed Ali Hosseini; Joseph Therriault; Étienne Aumont; Gleb Bezgin; Nesrine Rahmouni; Jenna Stevenson; Cécile Tissot; Marcel S. Woo; Stijn Servaes; Stuart Mitchell; Jaime Fernandez-Arias; Brandon Hall; Tevy Chan; Marina Pereira Gonçalves; Pamela C. L. Ferreira; João Pedro Ferrari-Souza; Bruna Bellaver; Firoza Z. Lussier; Andréa L. Benedet; Nicholas J. Ashton; Henrik Zetterberg; Kaj Blennow; Dana L. Tudorascu; Eduardo R. Zimmer; Maxime Montembeault; Jean-Paul Soucy; Jesse Klostranec; Tharick A. Pascoal; Paolo Vitali; Pedro Rosa-NetoShow moreShow less
Affiliations
1. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, McConnell Brain Imaging Centre (BIC), Montreal Neurological Institute, Montréal, Canada; 2. Department of Neurology and Neurosurgery, McGill University, Québec, Canada; 3. Montreal Neurological Institute, Québec, Canada; 4. Lawrence Berkeley National Laboratory, Berkeley, USA; 5. Translational Neurodegeneration Laboratory, Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6. Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 7. Graduate Program in Biological Sciences: Pharmacology and Therapeutics; and Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; 8. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; 9. Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, Sweden; 10. King’s College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK; 11. NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK; 12. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; 13. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; 14. UK Dementia Research Institute at UCL, London, UK; 15. Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; 16. Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA; 17. Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; 18. Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China; 19. Brain Institute of Rio Grande do Sul, Porto Alegre, Brazil; 20. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, USA; 21. The Peter O’Donnell Jr. Brain Institute (OBI), University of Texas Southwestern Medical Centre (UTSW), Dallas, USAShow moreShow less
236
days
Insulin resistance alters cortical inhibitory neurons and microglia to exacerbate Alzheimer’s knock-in mouse phenotypes
Authors
LaShae Nicholson; Si Jie Tang; Tejaswini Karra; Habiba Abouelatta; Stephen M. StrittmatterShow moreShow less
Affiliations
1. Departments of Neuroscience and Neurology, Yale School of Medicine, New Haven, USA; 2. Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale School of Medicine, New Haven, USA; 3. School of Medicine, University of California Davis Medical Center, Sacramento, USA; 4. Institute of Neuropathology, University Medical Centre Göttingen, Göttingen, Germany; 5. Department of Neuroscience and Behavior, Mount Holyoke College, South Hadley, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days